|4Feb 20, 4:41 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 20, 2015

Insider Transaction Report

Form 4
Period: 2015-02-18
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2015-02-18$27.22/sh452$12,30324,961 total

Documents

1 file
  • 4
    rrd422588.xmlPrimary